Related Experiment Video
Updated: May 5, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based
T M Laursen1, P B Mortensen1, J H MacCabe2
1National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark.
Insights
Individuals with schizophrenia or bipolar disorder show decreased cardiovascular drug prescriptions and significantly higher mortality rates, especially from unnatural causes, highlighting neglected cardiovascular risk factor treatment.
Area of Science:
- Psychiatry and Public Health
- Cardiovascular Epidemiology
Background:
- Cardiovascular co-morbidity is a primary driver of excess mortality in schizophrenia and bipolar disorder patients.
- Population-based studies investigating this link are limited.
Purpose of the Study:
- To investigate cardiovascular (CV) drug prescription rates and mortality risks in individuals with schizophrenia or bipolar disorder compared to the general population.
- To identify potential under-treatment of CV risk factors in these patient groups.
Main Methods:
- Utilized Danish population registers to calculate incidence rate ratios (IRRs) for CV drug use.
- Calculated mortality rate ratios comparing patients with schizophrenia or bipolar disorder to those without prior psychiatric hospitalization.
Main Results:
- CV prescription rates were significantly lower in patients with schizophrenia or bipolar disorder.
- These patients faced up to 6-fold and 15-fold increased mortality from all causes or unnatural causes, respectively, particularly when untreated for CV conditions.
- Excess mortality was lower but similar between treated and untreated individuals with prior cardiovascular disease.
Conclusions:
- Apparent under-prescription of CV drugs in Danish patients with schizophrenia or bipolar disorder.
- Excess mortality from unnatural causes in untreated patients suggests illness severity may confound CV treatment effects.
- Highlights a potential neglect in treating CV risk factors within this vulnerable population.
Background:
Cardiovascular (CV) co-morbidity is one of the major modifiable risk factors driving the excess mortality in individuals with schizophrenia or bipolar disorder. Population-based studies in this area are sparse.
Method:
We used Danish population registers to calculate incidence rate ratios (IRRs) for CV drug use, and mortality rate ratios comparing subjects with schizophrenia or bipolar disorder with subjects with no prior psychiatric hospitalization.
Results:
IRRs for CV prescriptions were significantly decreased in patients with schizophrenia or bipolar disorder compared with the general population. Among persons without previous myocardial infarction (MI) or cerebrovascular disease, persons with schizophrenia or bipolar disorder had an up to 6- and 15-fold increased mortality from all causes or unnatural causes, respectively, compared with the general population, being most pronounced among those without CV treatment (16-fold increase). Among those with previous MI or cerebrovascular disease, excess all-cause and unnatural death was lower (up to 3-fold and 7-fold increased, respectively), but was similar in CV-treated and -untreated persons.
Conclusions:
The present study shows an apparent under-prescription of most CV drugs among patients with schizophrenia or bipolar disorder compared with the general population in Denmark. The excess of mortality by unnatural deaths in the untreated group suggests that the association between CV treatment and mortality may be confounded by severity of illness. However, our results also suggest that treatment of CV risk factors is neglected in these patients.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Drug Dosing: Obese Patients
